Evidence map›Paper›PMID 42421078›Full record

ArticleArthritis research & therapy2026

DAS28-ESR may underestimate disease activity in rheumatoid arthritis patients with nonalcoholic fatty liver disease: a retrospective cohort study.

Yutaka Shinkawa, Masao Tanaka, Tomoya Nakajima, Masashi Taniguchi, Kyosuke Fukumori, Kayo McCracken, Mori Masato, Tomomi Sato-Nakamura, Takuji Nakamura, Shinji Hirose and 2 more

Abstract read
In one paragraph

Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yutaka ShinkawaCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan. mattari.shinshin@gmail.com.
Masao TanakaCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.
Tomoya NakajimaCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.
Masashi TaniguchiCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.
Kyosuke FukumoriCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.
Kayo McCrackenCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.
Mori MasatoCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.
Tomomi Sato-NakamuraCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.
Takuji NakamuraCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.
Shinji HiroseCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.
Akio MorinobuDepartment of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hisanori UmeharaCenter for Rheumatic Diseases, Nagahama City Hospital, 313 Oinui-cho, Nagahama, Shiga, 526-8580, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough approximately one-third of patients with rheumatoid arthritis (RA) have comorbid nonalcoholic fatty liver disease (NAFLD), the clinical characteristics of these patients remain unclear. The aim of this study was to clarify the clinical characteristics of RA patients classified as having NAFLD based on imaging, with a focus on composite disease activity assessment.

methodsThis retrospective cohort study analysed data from 349 RA patients enrolled in the Nagahama Riumachi Cohort between March 2017 and August 2023. Patients with liver diseases other than NAFLD were excluded. NAFLD was classified based on findings from abdominal computed tomography and/or ultrasonography performed during the cohort period. Disease activity was assessed using the Clinical Disease Activity Index (CDAI), Simplified Disease Activity Index (SDAI), Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP), and Disease Activity Score in 28 joints using erythrocyte sedimentation rate (DAS28-ESR). Functional status was evaluated using the Health Assessment Questionnaire Disability Index (HAQ-DI). Factors associated with NAFLD were examined by logistic regression, and repeated measurements during follow-up were analysed using linear mixed-effects models.

resultsSeventy-three patients (20.9%) were classified as having NAFLD and 276 (79.1%) as not having NAFLD. Patients in the NAFLD group were younger, had a higher proportion of men, and had a higher prevalence of body mass index (BMI) ≥ 25 kg/m². There were no significant differences between the groups in disease activity assessed by CDAI, SDAI, or DAS28-CRP. However, the NAFLD group had significantly lower DAS28-ESR and erythrocyte sedimentation rate (ESR) values despite similar C-reactive protein (CRP) levels. HAQ-DI was lower in the NAFLD group, especially in the lower-limb domain. In multivariable analysis, younger age and higher (BMI) were independently associated with NAFLD, but ESR and HAQ-DI were not significantly associated. In linear mixed-effects models, NAFLD classification was not significantly associated with ESR, although ESR tended to be lower in the NAFLD group.

conclusionsAmong patients with RA classified as having NAFLD, DAS28-ESR may underestimate disease activity compared with CRP-based or clinical indices. In these patients, DAS28-CRP, CDAI, and SDAI may provide complementary information.

Indexed as

Arthritis, RheumatoidNon-alcoholic Fatty Liver DiseaseSeverity of Illness IndexAdultAgedBlood SedimentationCohort StudiesC-Reactive ProteinFemaleHumansMaleMiddle AgedRetrospective StudiesC-Reactive ProteinDAS28-CRPDAS28-ESRDisease activityErythrocyte sedimentation rateNonalcoholic fatty liver diseaseRheumatoid arthritis

Identifiers

PMID42421078
PMCPMC13629014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.